Skip to Content

The Best Datreal Yet: Real Estate Maps, a New Design, Dark Mode. Read the Changelog

Datreal

Corpremans Clinical Trial Consultancy AB - Company Valuation

How Much Is Corpremans Clinical Trial Consultancy AB Worth?

Enterprise Value

15,114,331 kr
Range
11,082,619 kr–26,765,421 kr
Evidence Strength
Low
Based on FY
2025
Valuation Date
Business Strength
B+
Altman Z″
7.84
Risks
Insufficient Data

Scope & Evidence

Company
Corpremans Clinical Trial Consultancy AB
Registration
SE · 5593634412
Covers
Not stated in the filing
Filings Used
4 · FY 2025, 2024, 2023, 2022
Industry: NACE 72 · 3 Europe industry cohorts

Methodology & Assumptions

Industry EV / EBITDA
15.9×
Industry Revenue Multiple
3.95×
Revenue Multiple
3.95×
Enterprise Value
15,114,331 kr
Value Before Discount
15,114,331 kr

Key Ratios

Current Ratio
3.83×
Quick Ratio
-
Debt / Equity
1.09×
Equity Ratio
47.9%
Interest Coverage
≥ 100.00×
Gross Margin
-
Net Profit Margin
17.3%
Return on Equity
53.6%
Return on Assets
25.7%
Revenue CAGR
48.5%

Asset Distribution

CashReceivablesOther Assets

Liability Maturity

Short-TermLong-Term

3-Year Revenue Scenarios

14m kr
10.5m kr
7m kr
3.5m kr
0 kr
202620272028
OptimisticBaseConservative

Revenue vs Industry Peers

RISE Research Institutes of Sweden AB
4,394,000,000 kr
Amgen Aktiebolag
2,783,154,000 kr
Corpremans Clinical Trial Consultancy AB ★
4,425,467 kr
Dellstad Konsult AB
1,365,300 kr
Nelara Medical AB
196,820 kr
KarOlin Medical AB
102,000 kr

Revenue, Profit & EBITDA

6m kr
4.5m kr
3m kr
1.5m kr
0 kr
2022202320242025
RevenueNet Profit

Versus Industry Median

6m kr
4.5m kr
3m kr
1.5m kr
0 kr
RevenueNet Profit
This CompanyIndustry Median